HI
CRL icon

Handelsinvest Investeringsforvaltning’s Charles River Laboratories CRL Stock Holding History

Handelsinvest Investeringsforvaltning’s Portfolio CRL Stock Details CRL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		$411K Sell
1,518
-788
-34% -$188K 0.2% 105
2023
Q4 		$545K Sell
2,306
-17,694
-88% -$3.48M 0.22% 115
2023
Q3 		$3.92M Buy
+20,000
New +$4.11M 1.36% 21

Other funds holding CRL

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Kayne Anderson Rudnick Investment Management
Kayne Anderson Rudnick Investment Management Los Angeles, California $34B AUM 6.31% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
MG
Meritage Group San Francisco, California $2.65B AUM 6.3% 1-Year Est. Return
Allspring Global Investments
Allspring Global Investments Charlotte, North Carolina $59.7B AUM 29.08% 1-Year Est. Return
AI
Ariel Investments Chicago, Illinois $8.93B AUM 29.58% 1-Year Est. Return

Handelsinvest Investeringsforvaltning's CRL Position: Q1 2024 in Review

Handelsinvest Investeringsforvaltning reduced its Charles River Laboratories (CRL) stake by 34% in Q1 2024, selling an estimated $188K and leaving 1,518 shares worth $411K. The position accounts for 0.2% of the portfolio, ranked #105.

Handelsinvest Investeringsforvaltning first reported a position in CRL in Q3 2023 and has held it in 3 quarters since. The position peaked at $3.92M in Q3 2023. 677 funds tracked by Wall St. Rank hold CRL as of Q1 2024.

  • Handelsinvest Investeringsforvaltning held 1,518 shares of Charles River Laboratories worth $411K as of Q1 2024.
  • Handelsinvest Investeringsforvaltning sold 788 Charles River Laboratories shares in Q1 2024, an estimated $188K.
  • Charles River Laboratories made up 0.2% of Handelsinvest Investeringsforvaltning's portfolio in Q1 2024, its #105 holding.
  • Handelsinvest Investeringsforvaltning first reported a position in Charles River Laboratories in Q3 2023 and has held it in 3 quarters since.
  • Handelsinvest Investeringsforvaltning's Charles River Laboratories position peaked at $3.92M in Q3 2023.
  • 677 funds tracked by Wall St. Rank held Charles River Laboratories as of Q1 2024.

Based on Handelsinvest Investeringsforvaltning's 13F filing for Q1 2024, filed 19 Apr 2024.